ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic Infrastructure Catalyst in MASLD as GLP-1 Boom Accelerates — See Other Active Stocks
As the global healthcare system rapidly scales to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies, ENDRA Life Sciences (NASDAQ: NDRA) is emerging as a key name…
